Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash Flows From Operating Activities:
Net income (loss)	$ (583,165)	$ (1,193,499)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	449,648	446,546
Amortization of debt discount	0	36,338
Accretion of asset retirement obligation	4,386	3,074
Common stock issued for services	0	136,000
Common stock payable for directors fees	61,733	62,500
Other, non cash items	(660)	(598)
Change in:
Accounts receivable	50,817	21,386
Inventories	39,890	31,573
IVA receivable and other assets	(43,952)	1,679
Accounts payable	(256,368)	145,252
Accrued payroll, taxes and interest	(71,023)	82,845
Other accrued liabilities	47,355	35,782
Payables to related party	21,405	36,135
Net cash provided (used) by operating activities	(279,934)	(154,987)
Cash Flows From Investing Activities:
Payment received on note receivable	0	400,000
Purchase of properties, plants and equipment	(200,166)	(473,578)
Net cash provided (used) by investing activities	(200,166)	(73,578)
Cash Flows From Financing Activities:
Change in checks issued and payable	142,530	66,546
Net proceeds from (payment to) factor	612	(2,720)
Advances from related parties	0	227,200
Payments on advances from related party	(46,160)	0
Proceeds from note payable-SBA	443,400	0
Prceeds from notes payable to bank, net of payments	(31,135)	16,081
Principal payments of long-term debt	(21,238)	(89,430)
Net cash provided (used) by financing activities	488,009	217,677
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	7,909	(10,888)
Cash and cash equivalents and restricted cash at beginning of period	172,767	113,897
Cash and cash equivalents and restricted cash at end of period	180,676	103,009
Noncash investing and financing activities:
Common stock payable issued to directors	130,483	175,000
Payable to related party satisfied with exercise of stock purchase warrant	$ 62,500	$ 0